News and Events
As the U.S. Food and Drug Administration calls for further research into improving prescription drug advertising on television, experts from Dartmouth College and the University of Minnesota are calling for the nation to take a second look at online pharmaceutical information and promotion.
Every day, thousands of patients suffering from blood cancers like leukemia search for a bone marrow donor match. Sadly, six out of 10 patients today do not find a donor who can save their life. A group of students in Duluth are working hard to change that.
Jeanette Roberts, PhD, has been selected by the University’s Board of Regents to receive the Outstanding Achievement Award. The award is the U’s highest non-degree honor. University President Dr. Eric Kaler will present the award to Roberts on May. 23.
Roberts was recognized for her outstanding achievements as a leader in academic pharmacy and medicinal chemistry.
Nearly 30 million people in the United States suffer from conditions classified as “rare diseases” – defined by the Food and Drug Administration (FDA) as conditions affecting fewer than 200,000 people.
While some bear names you’ve likely never heard of, other examples may surprise you. Huntington’s disease, Tourette’s syndrome and muscular dystrophy are all classified as rare diseases. In all, more than 6,000 medical disorders are considered rare.
New research from the University of Minnesota College of Pharmacy and Masonic Cancer Center has found that consumption of the root of Piper methysticum, or kava, a plant native to the South Pacific Islands, may prevent the development of tobacco smoke-induced lung cancer.
Stephen Schondelmeyer, PhD, has been selected to receive the 2014 Tyler Prize for Stimulation of Research. The award recognizes an individual for encouraging research by peers, students, fellows, residents and others via publications or by directing research, serving as a preceptor, or mentoring in any discipline of the pharmaceutical sciences.